MOSTAL (pyrus malus- apple fruit extract solution

Mostal by

Drug Labeling and Warnings

Mostal by is a Otc medication manufactured, distributed, or labeled by Pella Pharmaceuticals Co. Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Forms and presentation

Topical Solution: Bottle of 50 ml.

Active Ingredient

Pyrus Malus (Apple) Fruit Extract (Procyanidine B2)

Inactive Ingredients

Aqua, Alcohol, Propylene Glycol, Sodium Citrate, Citric Acid.

Purpose

Hair growth enhancer

Properties

Mostal ® solution that helps to stop hair fall; improves hair growth and increases its density.

Indications

Mostal ® solution is recommended for men and women to stop hair fall; improves hair growth and increases its density.

Precautions

Keep out of reach of children

Warnings

• For external use only
• Avoid eye contact
• For accidental ingestion; seek professional attention, some redness and irritation is normal initially, if it persists discontinue use
• Avoid contact with fabrics until it dries out

Contraindications

Hypersensitivity to any of the components.

Side effects

Mostal ® solution has no known side effect, the use of it is without risk.

Dosage and administration

Spraying the solution on the scalp, the solution gently massaged into the scalp for 10 to 20 seconds, twice daily.
The increase in frequency of use, increases efficiency.

Storage conditions

Store at a temperature below 30 ° C.

Label

Secondary Package

INGREDIENTS AND APPEARANCE

MOSTAL 
pyrus malus (apple) fruit extract solution

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 82160-306
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
APPLE (UNII: B423VGH5S9) (APPLE - UNII:B423VGH5S9)	APPLE	500 mg  in 50 mL

Inactive Ingredients
Ingredient Name	Strength
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
ALCOHOL (UNII: 3K9958V90M)
WATER (UNII: 059QF0KO0R)
SODIUM CITRATE (UNII: 1Q73Q2JULR)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 82160-306-01	1 in 1 CARTON	01/20/2011
1		50 mL in 1 BOTTLE, GLASS; Type 0: Not a Combination Product
2	NDC: 82160-306-02	3 in 1 CARTON	01/20/2011
2		50 mL in 1 BOTTLE, GLASS; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		01/20/2011

Labeler - Pella Pharmaceuticals Co. Ltd (562370925)